SS-31 Peptide (Elamipretide) – Mitochondrial Research Peptide

SS-31 Peptide (Elamipretide) – Mitochondrial Research Peptide

Blog Article

SS-31 Peptide, also known as Elamipretide or MTP-131, is a synthetic mitochondria-targeted tetrapeptide researched for its interaction with cardiolipin, a phospholipid located in the inner mitochondrial membrane. Research has investigated its role in mitochondrial structure, bioenergetics, oxidative stress, and SS-31 Peptide (Elamipretide) cellular energy pathways.

SS-31 has been studied across mitochondrial and cellular research, including investigations involving mitochondrial dysfunction, muscle function, neurological pathways, cardiovascular research, and oxidative-stress mechanisms.

Product Highlights

SS-31 / Elamipretide / MTP-131

Mitochondria-targeted tetrapeptide

Researches cardiolipin and mitochondrial membrane pathways

Studied in mitochondrial bioenergetics

Investigated in oxidative-stress and cellular-energy research

Researched in mitochondrial disease and tissue-protection models

Potential Research Areas of SS-31 (Elamipretide)

Mitochondrial function: Studied for its interaction with cardiolipin and potential effects on mitochondrial structure and function.

Cellular energy research: Investigated in relation to mitochondrial respiration and oxidative phosphorylation.

Oxidative-stress research: Studied in models involving mitochondrial oxidative stress and cellular damage.

Mitochondrial membrane research: Research has examined how elamipretide affects mitochondrial membrane organization and cristae structure.

Muscle research: Investigated in mitochondrial myopathy and other conditions involving impaired mitochondrial function.

Neurological research: Preclinical research has examined SS-31 in models of neurological injury and mitochondrial dysfunction.

Cardiovascular research: Studied in relation to mitochondrial dysfunction and cardiac pathways.

Report this page